I sat down to breakfast with my cereal, orange juice, and bottle of pills. Around me were several undergraduates at the Massachusetts Institute of Technology (MIT), who lived with me at the cooperative house where I served as Resident Advisor from 2012 to 2014. When the conversation turned to my pills, I explained, as naturally as could be, that I was taking lithium carbonate to treat my mental-health diagnosis of Bipolar Disorder, Type II. As the students’ eyes widened, perhaps wondering about the fitness of their new RA for the job, I explained that mood disorders based in brain chemistry are extremely common, that treatment is easy, that I’ve never felt better since beginning treatment. With a confidence rooted in life experience, I said to the students that I am a high-functioning person who gets a lot done, who accomplished a lot as a student at MIT years ago, and who has continued that pattern through a leadership career in political technology and now into studying for the rabbinate.